4.7 Article

Update of CARTITUDE-1: A phase Ib/II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy, in relapsed/refractory multiple myeloma.

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 38, Issue 15_suppl, Pages 8505-8505

Publisher

American Society of Clinical Oncology (ASCO)
DOI: 10.1200/jco.2020.38.15_suppl.8505

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available